Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Subcutaneous and intravenous secukinumab formulations evaluated in plaque psoriasis

Oct. 28, 2011

MOC-carboetomidate induces hypnosis without adrenocortical suppression

Oct. 28, 2011

Trial confirms earlier results with PET imaging agent florbetaben (18F)

Oct. 28, 2011

Phase III data support safety of dextromethorphan hydrobromide/quinidine sulfate in MS

Oct. 28, 2011

New vaccine shows promise in several models of infection

Oct. 28, 2011

Phase II trial evaluates fingolimod in Japanese patients with MS

Oct. 27, 2011

Celiac disease candidate therapy completes proof-of-principle phase II study

Oct. 27, 2011

Influenza HA1-flagellin fusion vaccines well tolerated in healthy volunteers

Oct. 27, 2011

BF-200 ALA shows efficacy in treating actinic keratosis in advanced studies

Oct. 27, 2011

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...